Showing results (11-20 of 102) with videos related to
Sort By:
Pageof 11
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 1, 2009
BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humansLieuwe Appel, Yona Geffen, Kerstin Heurling, et al.Nuclear Medicine and Biology|March 26, 2013
5-Fluoro-[β-¹¹C]-L-tryptophan is a functional analogue of 5-hydroxy-[β-¹¹C]-L-tryptophan in vitro but not in vivoOlof Eriksson, Ramkumar Selvaraju, Beatrice Borg, et al.Nuclear Medicine and Biology|March 21, 2026
Novel approaches for PET imaging of endometriosisHongchao Zhang, Olof Eriksson, Matts Olovsson, et al.Nature Communications|February 20, 2016
Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's diseaseDag Sehlin, Xiaotian T Fang, Linda Cato, et al.Chemical Communications (Cambridge, England)|October 19, 2019
Rhodium-mediated <sup>18</sup>F-oxyfluorination of diazoketones using a fluorine-18-containing hypervalent iodine reagentMiguel A Cortés González, Xingguo Jiang, Patrik Nordeman, et al.EJNMMI Research|December 2, 2024
PET imaging of GABA<sub>A</sub> receptors in pancreatic islets by [<sup>11</sup>C]flumazenilFaïza Maloum-Rami, Pierre Cheung, Gunnar Antoni, et al.EJNMMI Research|June 28, 2015
Strategy to develop a MAO-A-resistant 5-hydroxy-L-[β-(11)C]tryptophan isotopologue based on deuterium kinetic isotope effectsJonas Eriksson, Ola Åberg, Ram Kumar Selvaraju, et al.Neuroimage|May 4, 2017
Combined PET and microdialysis for in vivo estimation of drug blood-brain barrier transport and brain unbound concentrationsSofia Gustafsson, Jonas Eriksson, Stina Syvänen, et al.Journal of Labelled Compounds & Radiopharmaceuticals|June 15, 2018
Automated GMP-production of α-[<sup>11</sup> C]methyl-L-tryptophan using a tracer production system (TPS)Patrik Nordeman, Ulrika Yngve, Helena Wilking, et al.Psychopharmacology|August 10, 2025
Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-humanLieuwe Appel, Robert Risinger, Anders Wall, et al.Pageof 11